Table 1.
CGG repeat primed PCR |
||||||
---|---|---|---|---|---|---|
CGG repeats |
||||||
Cell line | Sex | Submitted CGG repeat number | Fragment sizing* | Absolute quant* | CGG repeats (gene-specific PCR)† | Consensus‡ |
NA06890 | M | 30 | 30 | 30 | 30 | 30 |
CD00014 | M | 56 | 56 | 56 | 56 | 56 |
NA06891 | M | 118 | 119 | 123 | 119 | |
NA09145 | M | Full | >200 | >200 | >200 | |
NA06852 | M | >200 | >200 | >200 | >200 | |
NA06897 | M | 477 | >200 | >200 | >200 | |
NA07862 | M | 501–550 | >200 | >200 | >200 | |
NA04025 | M | 645 | >200 | >200 | >200 | |
NA07538 | F | 29/29 | 29 | 29 | 29 | 29 |
NA07541 | F | 29/31 | 29 | 29 | ||
31 | 31 | 31 | ||||
NA13664 | F | 28/49 (+/−3) | 30 | 30 | 30 | |
51 | 52 | 52 | ||||
NA20240 | F | 30/80 | 30 | 30 | 30 | 30 |
81 | 83 | 83 | 80 | |||
NA06896 | F | 23/95–140 | 23 | 23 | 23 | |
113 | 113 | |||||
133–138 | 133–138 | |||||
155 | 154 | |||||
175 | 176 | |||||
198 | 198 | |||||
>200 | >200 | |||||
NA20239 | F | 20/183–193 | 20 | 20 | 20 | 20 |
198 | 206 | 198 | NC | |||
>200 | >200 | |||||
NA07537 | F | 28/336 | 29 | 29 | 29 | |
>200 | >200 | >200 | ||||
NAO5847 | F | 21/650 | 20 | 20 | 20 | |
>200 | >200 | >200 | ||||
NA20238 | F | 29/30 | 29 | 29 | 29 | 29 |
30 | 30 | 30 | 30 | |||
NA20243 | F | 29/41 | 29 | 29 | 29 | 29 |
41 | 41 | 41 | 41 | |||
NA20235 | F | 29/45 | 29 | 29 | 29 | 29 |
45 | 45 | 45 | 45 | |||
NA20242 | F | 30/73 | 30 | 30 | 30 | 30 |
73 | 74 | 74 | 73 | |||
105 | 104 |
The “Submitted CGG repeat number” is that provided to and by CCR for the cell line DNA sample indicated. “Fragment sizing” refers to the determination of the CGG repeat number based upon the mobility of the full-length amplicon of the RP PCR reaction. “Absolute quant” indicates the number of CGG repeats based on peak counting alone.
NC, no consensus; M, male; F, female.
This study.
Gene-specific FMR1 PCR (8).
Consensus result from (13).